Answers are grounded in this paper and cite their sources.
Hypertonia occurs commonly in individuals with cerebral palsy and can impair comfort, functional progress, skin integrity and caretaking. In these cases, management of hypertonia is essential to improve function and quality of life. Non-surgical management of hypertonia can be achieved through non-pharmacologic, pharmacologic and procedural interventions, and in many cases a combination of these strategies is employed to optimize function and quality of life in those with cerebral palsy. Non-pharmacologic management includes the use of orthoses, physical and occupational therapies and the inclusion of evidence-based therapeutic techniques. Pharmacologic management is the use of enteral medication to minimize generalized hypertonia. Procedural management involves targeted injection of muscle groups or of nerves or their motor points and is typically used for focal hypertonia. In summary, hypertonia management involves a multidisciplinary approach and is tailored individually based on the severity, pattern and distribution of hypertonia, functional level, goals and social context. Commonly, multiple treatment modalities are used to achieve the best outcome for the individual.
No takes yet. Share an insight, caveat, or question.
Caine et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: